Impact of pre-existing T cell immunity to SARS-CoV-2 in uninfected individuals with COVID-19 mortality in different countries
View ORCID ProfileGennadi V. Glinsky
doi: https://doi.org/10.1101/2020.10.03.20206151
Gennadi V. Glinsky
1Institute of Engineering in Medicine, University of California, San Diego, 9500 Gilman Dr. MC 0435, La Jolla, CA 92093-0435, USA

Article usage
Posted October 12, 2020.
Impact of pre-existing T cell immunity to SARS-CoV-2 in uninfected individuals with COVID-19 mortality in different countries
Gennadi V. Glinsky
medRxiv 2020.10.03.20206151; doi: https://doi.org/10.1101/2020.10.03.20206151
Subject Area
Subject Areas
- Addiction Medicine (161)
- Allergy and Immunology (414)
- Anesthesia (90)
- Cardiovascular Medicine (857)
- Dermatology (97)
- Emergency Medicine (248)
- Epidemiology (8560)
- Gastroenterology (383)
- Genetic and Genomic Medicine (1749)
- Geriatric Medicine (167)
- Health Economics (372)
- Health Informatics (1239)
- Health Policy (620)
- Hematology (196)
- HIV/AIDS (372)
- Medical Education (192)
- Medical Ethics (51)
- Nephrology (211)
- Neurology (1677)
- Nursing (97)
- Nutrition (250)
- Oncology (928)
- Ophthalmology (263)
- Orthopedics (101)
- Otolaryngology (172)
- Pain Medicine (113)
- Palliative Medicine (40)
- Pathology (252)
- Pediatrics (534)
- Primary Care Research (207)
- Public and Global Health (3835)
- Radiology and Imaging (623)
- Respiratory Medicine (520)
- Rheumatology (208)
- Sports Medicine (158)
- Surgery (190)
- Toxicology (36)
- Transplantation (101)
- Urology (76)